Protocol 2: conservative microdosing approach (5 mg/mL vial) Goal: Minimize side effects with a gradual introduction
The researchers confirmed that while both lean and fat mass are reduced during treatment, the reduction in fat mass is more substantial, resulting in an overall favorable change in body composition
The medication has been approved by the FDA in several countries, indicating its safety when used under medical supervision
This offers a proactive, complementary option for addressing the demands of living with CHF
Putting two or more together, something people call "peptide stacking," is said to promote protein synthesis and muscle repair, leading to increased muscle mass and strength
Common Vs Less Common Side Effects Common gastrointestinal effects include nausea, vomiting, diarrhea, constipation, indigestion, bloating, delayed gastric emptying, and excess gas or burping